Access personalized Castleman Disease Treatment care using advanced medical technology, supported by expert specialists and dedicated international patient services.
University Hospital provides Castleman Disease Treatment using contemporary haematology and immunotherapy approaches, along with evidence-based care. Founded in 1842, the SAC accredited hospital is based in Basel, Switzerland, with 773 beds and services for domestic and international patients.
The treatment approach depends on the subtype and severity of the disease. For unicentric Castleman disease, complete surgical removal may be sufficient in many cases. Multicentric disease may require systemic therapy, including medicines that target inflammatory pathways, corticosteroids, or other treatments based on the underlying cause and clinical presentation.
